September 24–26, 2026
Cambridge, MA

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

The CMT Research Foundation unites the voices of patients, researchers, pharma companies, investors and regulatory agencies to develop treatments for CMT.
This event takes place over three days. Thursday and Friday are scientific meetings tailored toward investors, researchers and scientists working to better understand, and ultimately, end CMT. Saturday is primarily for patients and their families, providing a chance to interact with and inform the research community that is working so hard on their behalf. Attendees will have the opportunity to engage with others in the patient community, better understand their disease, and learn how they can participate in the latest research progress.
The convention programming for Thursday and Friday offers a rare opportunity to engage directly with the researchers shaping the CMT pipeline, identify collaboration and investment opportunities, and gain a ground-level view of where the field is headed.
  • Thursday features cutting-edge learnings in CMT research, including new biological discoveries as well as advances in genetic and genomic technologies.
  • Don’t miss Friday’s keynote from Dr. Anna Greka, the founder of the Ladders to Cures (L2C) Scientific Accelerator at the Broad Institute of MIT and Harvard.
  • Saturday features programming for patients, creating unique opportunities for interaction, including recruitment through the convention’s Clinical Trial Fair.
With more active drug trials in CMT than ever before, the timing has never been better to get in the room. 

For the Scientific Community

September 24-25th

Two days for researchers, industry and government agencies to:

  • EXPLORE cutting-edge and emerging research in CMT
  • ADDRESS major barriers and opportunities in CMT drug development to accelerate progress
  • ENGAGE with researchers, industry experts and patients to build momentum toward developing approved CMT treatments

Purchase Tickets

For the Patient Community

September 26th

A day for the patient community to:

 

  • LEARN about the latest developments and clinical trials in CMT
  • INTERACT with distinguished scientific experts and clinicians
  • ACT to speed treatments for patients and families
Purchase Tickets

Hotel Information

The Royal Sonesta Boston

40 Edwin H Land Blvd
Cambridge, MA 02142

Discounted hotel rates are available for Convention attendees. To reserve your room within our group block, click here.

Sponsored by:

If you are interested in securing a sponsorship opportunity, please contact Anna Combes at [email protected].

The Scientific Programming Committee

Bruce Carter, MD, PhD

Professor of Biochemistry and Associate Director of the Brain Institute

Vanderbilt University

Jenneen DeFiore

Vice President – Neuroscience

PPD part of Thermo Fisher Scientific

Yulia Grishchuk, PhD

Associate Director of Regulatory Affairs at the Gene and Cell Therapy Institute

Mass General Brigham

Marina Kennerson, PhD

Professor of Neurogenetics 

ANZAC Research Institute and Sydney Medical School 

Brett McCray, MD, PhD

Assistant Professor of Neurology
University of Michigan

 

Wolfgang Pernice, PhD

Assistant Professor of Neurological Sciences

Columbia University